
Tariff fight escalates as Trump appeals second court loss
The Trump administration is fighting to pause a second court ruling that blocked President Donald Trump's sweeping and so-called reciprocal tariffs, the signature economic policy of his second term.
The administration's new appeal, filed Monday in the U.S. Court of Appeals for the D.C. Circuit, comes less than a week after a very similar court challenge played out in the U.S. Court of International Trade (CIT) in New York, and the U.S. Court of Appeals for the Federal Circuit in Washington.
At issue in both cases is Trump's use of the International Emergency Economic Powers Act to enact his sweeping "Liberation Day" tariff plan. The plan, which Trump announced on April 2, invokes IEEPA for both his 10% baseline tariff on most U.S. trading partners and a so-called "reciprocal tariff" against other countries.
Trump's use of the emergency law to invoke widespread tariffs was struck down unanimously last week by the three-judge CIT panel, which said the statute does not give Trump "unbounded" power to implement tariffs. However, the decision was almost immediately stayed by the U.S. Court of Appeals, allowing Trump's tariffs to continue.
But in a lesser-discussed ruling on the very same day, U.S. District Judge Rudolph Contreras, an Obama appointee, determined that Trump's tariffs were unlawful under IEEPA.
Since the case before him had more limited reach than the case heard by the CIT – plaintiffs in the suit focused on harm to two small businesses, versus harm from the broader tariff plan – it went almost unnoticed in news headlines.
But that changed on Monday.
Lawyers for the Justice Department asked the U.S. Court of Appeals for the D.C. Circuit – a Washington-based but still separate court than the Federal Court of Appeals – to immediately stay the judge's ruling.
They argued in their appeal that the judge's ruling against Trump's use of IEEPA undercuts his ability to use tariffs as a "credible threat" in trade talks, at a time when such negotiations "currently stand at a delicate juncture."
"By holding the tariffs invalid, the district court's ruling usurps the President's authority and threatens to disrupt sensitive, ongoing negotiations with virtually every trading partner by undercutting the premise of those negotiations – that the tariffs are a credible threat," Trump lawyers said in the filing.
Economists also seemed to share this view that the steep tariffs were more a negotiating tactic than an espousal of actual policy, which they noted in a series of interviews last week with Fox News Digital.
The bottom line for the Trump administration "is that they need to get back to a place [where] they are using these huge reciprocal tariffs and all of that as a negotiating tactic," William Cline, an economist and senior fellow emeritus at the Peterson Institute for International Economics, said in an interview.
Cline noted that this was the framework previously laid out by Treasury Secretary Scott Bessent, who had embraced the tariffs as more of an opening salvo for future trade talks, including between the U.S. and China.
"I think the thing to keep in mind there is that Trump and Vance have this view that tariffs are beautiful because they will restore America's Rust Belt jobs and that they'll collect money while they're doing it, which will contribute to fiscal growth," said Cline, the former deputy managing director and chief economist of the Institute of International Finance.
"Those are both fantasies."
What comes next in the case remains to be seen. The White House said it will take its tariff fight to the Supreme Court if necessary. Counsel for the plaintiffs echoed that view in an interview with Fox News.
But it's unclear if the Supreme Court would choose to take up the case, which comes at a time when Trump's relationship with the judiciary has come under increasing strain.
In the 20 weeks since the start of his second White House term, lawyers for the Trump administration have filed 18 emergency appeals to the high court, indicating both the pace and breadth of the tense court battles.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Miami Herald
13 minutes ago
- Miami Herald
Can Trump Tackle US ‘Chronic Disease Crisis'? Experts Weigh In
Health and Human Services Secretary Robert F. Kennedy Jr.'s vow to "Make America Healthy Again" could fall short when it comes to chronic disease, experts have warned. When the MAHA Commission report on chronic disease came out in May, President Donald Trump made it clear his administration was committed to tackling the epidemic "We will not stop until we defeat the chronic disease epidemic in America, we're going to get it done for the first time ever," said Trump during a MAHA event at the White House on May . In a statement included in the press release accompanying the report, Kennedy Jr. said: "We will end the childhood chronic disease crisis by attacking its root causes head-on-not just managing its symptoms." Nearly 130 million Americans are estimated to have at least one form of chronic disease, which could be heart disease, cancer, diabetes, obesity or hypertension, according to the Centers for Disease Control and Prevention. Experts told Newsweek that, while the Trump administration's ambition to "defeat" the "epidemic" is clear, whether its policies will help or hinder chronic-disease patients remains to be seen. On one hand, Kennedy Jr.'s recent MAHA report, which detailed what the administration believed to be the leading causes of chronic disease in children, indicated the aim was to reduce the prevalence of chronic conditions through public education and research. On the other hand, the proposed cuts to Medicaid funding and work requirements for eligibility to the benefits, which are set to come as part of the broader GOP budget bill, could leave many with chronic disease without access to vital care. As many as three in four adults enrolled in Medicaid report having one or more chronic conditions, and many are unable to work the hours needed to meet the new eligibility requirements, according to nonprofit health policy research and news organization, KFF. So, while some may be medically exempt, others will lose their health coverage, meaning their conditions could worsen without access to care. Newsweek has contacted the Department of Health and Human Services (HHS) via email on Tuesday. Since he became health secretary, Kennedy Jr. has promised to increase research in the root causes of illness and ensure the American diet is full of high-quality foods, while limiting access to ultra-processed food and certain chemicals, which he believes are contributors to chronic disease. The report states that consumption of ultra-processed foods "has gone up at an exponential rate as share of the American diet." Earlier in the year, Kennedy, had described products from companies like Kellogg's and McDonald's as "mass poison to children." Prioritizing research on the issue is crucial, Kenneth E. Thorpe, a professor of health policy at Emory University, Georgia, and honorary chair of the Partnership to Fight Chronic Disease (PFCD), told Newsweek. "Renewed focus on chronic disease and the impact that the U.S. diet has on it-focusing on artificial or chemical ingredients in food, particularly the impact of ultra processed foods-is important," he said. He added that this was because of the fact diet has "a direct impact on the growing rates of chronic conditions like obesity and obesity-related comorbidities such diabetes, cardiovascular disease, cancers and many more." "I applaud the Trump administration's focus on addressing the number one cause of death and disability in the U.S.-chronic, non-communicable disease," said Thorpe, who has been an advocate of chronic disease prevention in the U.S. for over 30 years. "We have more people with more chronic diseases, with just 5 percent of the population accounting for 50 percent of the costs in health care." He added that it is estimated that from 2016 to 2030 the cost of chronic disease will be in excess of $42 trillion. "The time is now to focus on the prevention and better management of chronic disease," Thorpe added. While it's too early to tell if the Trump administration is heading down the right path to lower chronic disease prevalence, Dr. Adrian Hernandez, director of the Duke Clinical Research Institute at the Duke University School of Medicine, told Newsweek that "leading indicators appear to be going the wrong way." He said this was partly because of the changes being proposed to the National Institutes of Health (NIH). A proposal for the HHS, most of which was reported on in April, reduces by almost 40 percent its budget for 2026 and reveals major funding cuts for the NIH, according to CNN. Newsweek has contacted the NIH via email on Tuesday. Hernandez added that changes, such as the proposed cuts in federal funding, to the Food and Drug Administration (FDA) and other agencies within the Department of Health and Human Services (HHS) were also going down the wrong path. Rather than cuts to these federal health agencies, Hernandez said tackling chronic disease will require "an investment" in science and health. He said that the same was needed for health care delivery models like Medicaid and Medicare-rather than making cuts to the programs, the administration should "invest in preventative health." The GOP budget bill, which is progressing through the legislative ranks, instructs the committee to reduce the Department of Health and Human Services budget by $880 billion over 10 years, which would include cuts to Medicaid alongside other measures such as implementing work requirements. Ross Brownson, director of the Prevention Research Center at Washington University in St. Louis, Missouri, told Newsweek that Medicaid cuts would "likely have a detrimental effect on chronic disease risk among the most vulnerable populations," adding Medicaid-enrolled adults have significantly higher rates of chronic disease than individuals privately insured. "The drive to defeat chronic disease stalls if Medicaid patients are placed in the backseat," Thorpe said. "Today, the federal program is far from perfect, but it is a lifeline for those who need it," Thorpe added, saying it was "often the only pathway to care" for many with chronic disease. Experts insist that chronic disease is a deeply complex issue that requires long-term solutions and attention. Brownson noted that there has been "sparse attention to physical inactivity and tobacco use," as major risk factors for chronic disease. "This is a two-edged sword," Brownson told Newsweek. He said that while "on one hand, labeling this issue a crisis implies a sense of urgency and may mobilize action." Ultimately "the jury is still out on whether they will solve the chronic disease crisis." "We often have a short attention span and with this crisis label, policy makers may think the problem can be solved quickly and then move on to a new issue. We need to think of this as a long-term challenge in need of attention," he added. Related Articles Foods That May Lower Risk of Early Death RevealedRFK Is Right-Food Additive Transparency Can Make America Healthy Again | OpinionManaging PoTS: Tips for Living with the Chronic Illness Affecting MillionsWhat to Eat When You're Living With Long COVID 2025 NEWSWEEK DIGITAL LLC.

Miami Herald
13 minutes ago
- Miami Herald
Donald Trump's Scores Highest Approval Rating in Weeks
President Donald Trump has scored his highest approval rating in two weeks. A new survey by Republican pollster Trafalgar Group, conducted May 30 to June 1, suggested 54 percent of voters approved, while 46 percent disapproved—a net approval rating of +8. Trump's approval rating has not been higher among any pollster since InsiderAdvantage's poll conducted May 17 to 19, when 55 percent of those surveyed approved and 44 percent disapproved—a net approval rating of +11. The new Trafalgar poll was conducted among 1,098 voters had a margin of error of 2.9 percentage points. This article will be updated. Related Articles Elon Musk Issues Social Security Warning Over Spending BillMortgage Rates Are Trapped in 'Groundhog Day'Kid Rock's New Restaurant Flooded With Negative Reviews: 'Trash Food'Can Trump Tackle US 'Chronic Disease Crisis'? Experts Weigh In 2025 NEWSWEEK DIGITAL LLC.

Miami Herald
14 minutes ago
- Miami Herald
Iran Breaks Silence on U.S. Nuclear Offer
Iranian Foreign Minister Abbas Araghchi offered a critical initial response to a recent U.S. proposal to resolve the standoff over Iran's nuclear program, according to the country's semi-official Mehr News Agency. Newsweek has reached out to the U.S. State Department for comment. The remarks are the first time Tehran has commented on the content of the recent U.S. proposal, which has not made public and came after five rounds of nuclear talks over the past two months. Iran's stance falls short of President Donald Trump's recent announcement about the possibility of reaching a nuclear agreement in the near future. Trump has threatened possible military action if no deal can be reached. Araghchi said the U.S. proposal handed to Tehran by the Omani foreign minister "contains many ambiguities and questions. Many issues in this proposal are unclear," he was quoted as saying by Mehr News Agency, while on a visit to Lebanon. The two nations have been at odds over nuclear enrichment - which could be used to build nuclear weapons, but which Iran says is purely for peaceful purposes. The United States has opposed all enrichment and Iran has defended its right to it. According to an Axios report citing two sources with direct knowledge of the matter, the U.S. proposal may have a presented a more flexible approach than the U.S. zero nuclear enrichment policy-allowing it for a determined period of time but banning Iran from building new enrichment facilities. Trump has said Iran can never obtain a nuclear bomb. The proposal sent by Middle East Special Envoy Steve Witkoff was described as a "detailed and acceptable proposal to the Iranian regime," by White House spokesperson Karoline Leavitt, who added that "it's in their best interest to accept it." Foreign Minister Abbas Araghchi said: "Continuing enrichment on Iranian soil is our red line. This is a reality that all countries have accepted. Enrichment has now become a matter of national pride and honor for Iranians." U.S. State Department Spokesperson Tammy Bruce said in a Tuesday press briefing: "The fact is President Trump tweeted that there is going to be no uranium enrichment." Araghchi, who leads the Iranian negotiation team in nuclear meetings with the U.S., said Iran will officially respond to the deal proposal in coming days. It is unclear if talks will resume. Related Articles Iran Warns US Over Nuclear Talks as Doubts Grow on Trump DealVideo Shows Iranian Warplane Patrol Skies in Show of ForceIran Reviews US Nuclear Deal Offer Amid Rising TensionsIran's Dissident Kurds Seek US Help to Pave Way for Government's 'Collapse' 2025 NEWSWEEK DIGITAL LLC.